We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

115 hedge funds and large institutions have $76.7M invested in VivoSim Labs in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

0% more ownership

Funds ownership: 0.1% → 0.1% (+0%)

6% less capital invested

Capital invested by funds: $81.4M → $76.7M (-$4.72M)

10% less funds holding

Funds holding: 128 → 115 (-13)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

58% less call options, than puts

Call options by funds: $722K | Put options by funds: $1.71M

Holders
115
Holders Change
-13
Holders Change %
-10.16%
% of All Funds
2.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
34
Reduced
29
Closed
16
Calls
$722K
Puts
$1.71M
Net Calls
-$984K
Net Calls Change
+$1.86M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$24.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.1M
3
UBS Group
UBS Group
Switzerland
+$1.01M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$973K
5
AIM
ARK Investment Management
Florida
+$528K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.72M
2
Norges Bank
Norges Bank
Norway
-$1.03M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$610K
4
Citigroup
Citigroup
New York
-$232K
5
QIM
Quantitative Investment Management
Virginia
-$231K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$336K +$38.8K +49 +13%
LPL Financial
27
LPL Financial
California
$326K +$4.75K +6 +1%
Goldman Sachs
28
Goldman Sachs
New York
$301K -$9.51K -12 -3%
CS
29
Credit Suisse
Switzerland
$289K -$80K -101 -21%
Cambridge Investment Research Advisors
30
Cambridge Investment Research Advisors
Iowa
$287K -$792 -1 -0.3%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$273K – – –
SPC
32
Sigma Planning Corp
Michigan
$269K +$57K +72 +26%
AFG
33
Albion Financial Group
Utah
$243K – – –
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$239K +$33.3K +42 +15%
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$238K +$146K +184 +143%
AllianceBernstein
36
AllianceBernstein
Tennessee
$232K – – –
Group One Trading
37
Group One Trading
Illinois
$231K +$240K +303 New
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$218K +$29.3K +37 +15%
ProShare Advisors
39
ProShare Advisors
Maryland
$213K -$57K -72 -21%
NFA
40
Nationwide Fund Advisors
Ohio
$193K +$22.2K +28 +13%
AIG
41
American International Group
New York
$170K +$13.5K +17 +8%
Deutsche Bank
42
Deutsche Bank
Germany
$168K -$170K -214 -49%
LTFS
43
Ladenburg Thalmann Financial Services
Florida
$150K -$8.71K -11 -5%
VOYA Investment Management
44
VOYA Investment Management
Georgia
$139K – – –
PPA
45
Parametric Portfolio Associates
Washington
$135K -$7.92K -10 -5%
CAS
46
Cue Advisory Services
Arizona
$135K – – –
Citigroup
47
Citigroup
New York
$128K -$232K -293 -64%
Citadel Advisors
48
Citadel Advisors
Florida
$127K -$57.8K -73 -31%
UBS AM
49
UBS AM
Illinois
$125K – – –
PCM
50
Prelude Capital Management
New York
$124K +$128K +162 New
1
2
3 4 5

VIVS Hedge Fund Activity: Q1 2017 in Review

115 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2017, worth a combined $76.7M — down 5.8% from $81.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of VIVS and 10 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 34 added.

The largest buyer was BlackRock, adding an estimated $24.9M. The largest seller was Susquehanna International Group, cutting an estimated $2.72M.

  • 115 institutional investors held VivoSim Labs (VIVS) as of Q1 2017, down from 128 in Q4 2016.
  • Funds reported $76.7M of VivoSim Labs stock for Q1 2017, down 5.8% quarter-over-quarter.
  • 10 funds opened new VivoSim Labs positions in Q1 2017 and 16 closed out, a net change of -6 holders.
  • The largest VivoSim Labs buyer in Q1 2017 was BlackRock, an estimated $24.9M added.
  • The largest VivoSim Labs seller in Q1 2017 was Susquehanna International Group, an estimated $2.72M sold.

Based on aggregated 13F filings for Q1 2017.